These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 25876687

  • 1. [Outcome of hepatoblastoma: experience with 63 patients received chemotherapy with the regimen C5V].
    Liu G, Liu B, Li K, Dong K, Xiao X.
    Zhonghua Er Ke Za Zhi; 2015 Feb; 53(2):119-23. PubMed ID: 25876687
    [Abstract] [Full Text] [Related]

  • 2. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.
    Ortega JA, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Finegold MJ, Haas JE, King DR, Liu-Mares W, Sensel MG, Krailo MD.
    J Clin Oncol; 2000 Jul; 18(14):2665-75. PubMed ID: 10894865
    [Abstract] [Full Text] [Related]

  • 3. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
    Malogolowkin MH, Katzenstein H, Krailo MD, Chen Z, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Womer RB, London WB, Castleberry RP.
    J Clin Oncol; 2006 Jun 20; 24(18):2879-84. PubMed ID: 16782927
    [Abstract] [Full Text] [Related]

  • 4. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Jun 20; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 5. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
    Katzenstein HM, Langham MR, Malogolowkin MH, Krailo MD, Towbin AJ, McCarville MB, Finegold MJ, Ranganathan S, Dunn S, McGahren ED, Tiao GM, O'Neill AF, Qayed M, Furman WL, Xia C, Rodriguez-Galindo C, Meyers RL.
    Lancet Oncol; 2019 May 20; 20(5):719-727. PubMed ID: 30975630
    [Abstract] [Full Text] [Related]

  • 6. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor.
    Sasaki F, Matsunaga T, Iwafuchi M, Hayashi Y, Ohkawa H, Ohira M, Okamatsu T, Sugito T, Tsuchida Y, Toyosaka A, Nagahara N, Nishihira H, Hata Y, Uchino J, Misugi K, Ohnuma N, (Japanese Study Group for Pediatric Liver Tumor).
    J Pediatr Surg; 2002 Jun 20; 37(6):851-6. PubMed ID: 12037748
    [Abstract] [Full Text] [Related]

  • 7. Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
    Sunil BJ, Palaniappan R, Venkitaraman B, Ranganathan R.
    J Gastrointest Cancer; 2018 Dec 20; 49(4):493-496. PubMed ID: 28963691
    [Abstract] [Full Text] [Related]

  • 8. Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
    Katzenstein HM, London WB, Douglass EC, Reynolds M, Plaschkes J, Finegold MJ, Bowman LC.
    J Clin Oncol; 2002 Aug 15; 20(16):3438-44. PubMed ID: 12177104
    [Abstract] [Full Text] [Related]

  • 9. Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma.
    Carceller A, Blanchard H, Champagne J, St-Vil D, Bensoussan AL.
    J Pediatr Surg; 2001 May 15; 36(5):755-9. PubMed ID: 11329582
    [Abstract] [Full Text] [Related]

  • 10. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A, Laithier V, Otte JB, de Camargo B, MacKinlay G, Scopinaro M, Aronson D, Plaschkes J, Perilongo G.
    J Clin Oncol; 2010 May 20; 28(15):2584-90. PubMed ID: 20406943
    [Abstract] [Full Text] [Related]

  • 11. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.
    von Schweinitz D, Byrd DJ, Hecker H, Weinel P, Bode U, Bürger D, Erttmann R, Harms D, Mildenberger H.
    Eur J Cancer; 1997 Jul 20; 33(8):1243-9. PubMed ID: 9301450
    [Abstract] [Full Text] [Related]

  • 12. Improved long-term survival with preoperative chemotherapy for hepatoblastoma.
    Ehrlich PF, Greenberg ML, Filler RM.
    J Pediatr Surg; 1997 Jul 20; 32(7):999-1002; discussion 1002-3. PubMed ID: 9247221
    [Abstract] [Full Text] [Related]

  • 13. Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study.
    Katzenstein HM, Malogolowkin MH, Krailo MD, Piao J, Towbin AJ, McCarville MB, Tiao GM, Dunn SP, Langham MR, McGahren ED, Finegold MJ, Ranganathan S, Weldon CB, Thompson PA, Trobaugh-Lotrario AD, O'Neill AF, Furman WL, Chung N, Randazzo J, Rodriguez-Galindo C, Meyers RL.
    Cancer; 2022 Mar 01; 128(5):1057-1065. PubMed ID: 34762296
    [Abstract] [Full Text] [Related]

  • 14. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
    Suita S, Tajiri T, Takamatsu H, Mizote H, Nagasaki A, Inomata Y, Hara T, Okamura J, Miyazaki S, Kawakami K, Eguchi H, Tsuneyoshi M, Committee for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.
    J Pediatr Surg; 2004 Feb 01; 39(2):195-8; discussion 195-8. PubMed ID: 14966739
    [Abstract] [Full Text] [Related]

  • 15. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.
    O'Neill AF, Towbin AJ, Krailo MD, Xia C, Gao Y, McCarville MB, Meyers RL, McGahren ED, Tiao GM, Dunn SP, Langham MR, Weldon CB, Finegold MJ, Ranganathan S, Furman WL, Malogolowkin M, Rodriguez-Galindo C, Katzenstein HM.
    J Clin Oncol; 2017 Oct 20; 35(30):3465-3473. PubMed ID: 28892430
    [Abstract] [Full Text] [Related]

  • 16. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma.
    Venkatramani R, Stein JE, Sapra A, Genyk Y, Jhaveri V, Malogolowkin M, Mascarenhas L.
    Br J Surg; 2015 Jan 20; 102(1):108-13. PubMed ID: 25349947
    [Abstract] [Full Text] [Related]

  • 17. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study.
    Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Liu-Mares W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC.
    J Clin Oncol; 2002 Jun 15; 20(12):2789-97. PubMed ID: 12065555
    [Abstract] [Full Text] [Related]

  • 18. Current chemotherapeutic approaches for hepatoblastoma.
    Watanabe K.
    Int J Clin Oncol; 2013 Dec 15; 18(6):955-61. PubMed ID: 24052132
    [Abstract] [Full Text] [Related]

  • 19. [Treatment outcome of 100 patients with hepatoblastoma based on a new risk stratification].
    Zhen ZZ, Liu JC, Zhou L, Xu Z, Zhang ZC, Sun FF, Lu SY, Zhu J, Wang J, Huang JT, Sun XF.
    Zhonghua Zhong Liu Za Zhi; 2021 Feb 23; 43(2):228-232. PubMed ID: 33601490
    [Abstract] [Full Text] [Related]

  • 20. Fibrolamellar hepatocellular carcinoma in children and adolescents.
    Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC.
    Cancer; 2003 Apr 15; 97(8):2006-12. PubMed ID: 12673731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.